Steward Partners Investment Advisory, LLC Incyte Corp Transaction History

Steward Partners Investment Advisory, LLC

$11 Billion
Q4 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Incyte Corp stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 871 shares of INCY stock, worth $53,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares

871

Previous 846 2.96%

Holding current value

$53,932

Previous $55,000 9.09%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$65.08 - $83.38 $1,627 - $2,084	25 Added 2.96%	871 $60,000
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $11,408 - $13,653	-199 Reduced 19.04%	846 $55,000
Q2 2024 Aug 08, 2024	SELL	$51.18 - $63.75 $61,620 - $76,755	-1,204 Reduced 53.53%	1,045 $63,000
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $6,277 - $7,391	111 Added 5.19%	2,249 $128,000
Q4 2023 Feb 12, 2024	BUY	$52.16 - $64.19 $65,095 - $80,109	1,248 Added 140.22%	2,138 $134,000
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $31,311 - $35,734	542 Added 155.75%	890 $51,000
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $14,445 - $17,895	237 Added 213.51%	348 $21,000
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $5,267 - $6,450	-75 Reduced 40.32%	111 $8,000
Q1 2022 May 02, 2022	SELL	$66.02 - $79.71 $5,875 - $7,094	-89 Reduced 32.36%	186 $15,000
Q4 2021 Feb 08, 2022	SELL	$63.34 - $74.11 $25,969 - $30,385	-410 Reduced 59.85%	275 $20,000
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $2,472 - $3,024	36 Added 5.55%	685 $47,000
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $4,312 - $4,726	-54 Reduced 7.68%	649 $55,000
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $6,765 - $8,944	89 Added 14.5%	703 $0
Q4 2020 Feb 11, 2021	BUY	$80.74 - $97.7 $21,234 - $25,695	263 Added 74.93%	614 $53,000
Q2 2020 Aug 06, 2020	BUY	$74.18 - $108.93 $2,670 - $3,921	36 Added 11.43%	351 $36,000
Q1 2020 Apr 29, 2020	SELL	$63.18 - $85.97 $52,186 - $71,011	-826 Reduced 72.39%	315 $23,000
Q4 2019 Jan 17, 2020	SELL	$73.04 - $95.72 $53,173 - $69,684	-728 Reduced 38.95%	1,141 $99,000
Q3 2019 Oct 30, 2019	SELL	$72.82 - $86.52 $364 - $432	-5 Reduced 0.27%	1,869 $138,000
Q2 2019 Jul 25, 2019	SELL	$73.52 - $88.7 $121,160 - $146,177	-1,648 Reduced 46.79%	1,874 $159,000
Q1 2019 Apr 30, 2019	BUY	$63.56 - $88.17 $223,858 - $310,534	3,522 New	3,522 $302,000
Q4 2018 Jan 15, 2019	SELL	$58.5 - $69.94 $3,100 - $3,706	-53 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$83.06 - $100.98 $3,156 - $3,837	-38 Reduced 41.76%	53 $4,000
Q3 2017 Nov 22, 2017	BUY	$109.15 - $138.27 $1,418 - $1,797	13 Added 16.67%	91 $10,000
Q2 2017 Nov 22, 2017	SELL	N/A	-122 Reduced 61.0%	78 $9,000
Q1 2017 Nov 22, 2017	BUY	N/A	200	200 $26,000

Others Institutions Holding INCY

# of Institutions

707

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Incyte Corp Transaction History